Mepolizumab Treatment for Rhinovirus-induced Asthma Exacerbations
The Prednisone-sparing Effect of Anti-IL-5 Antibody (SB-240563)
|3||Enrolling by invitation||
Anti-Interleukin-5 (IL5) Monoclonal Antibody (MAb) in Prednisone-dependent Eosinophilic Asthma
|4||Active, not recruiting||
Effects of cKit Inhibition by Imatinib in Patients With Severe Refractory Asthma (KIA)
† Study has passed its completion date and status has not been verified in more than two years.